News for Jerash Holdings (US), Inc. (JRSH)

Texas-based Moleculin Biotech, Inc. (MBRX), a clinical stage pharmaceutical company is up over 53 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Revenue: Increased 28.6% to $35.4 million from $27.5 million year-over-year.Gross Profit: Increased 20.6% to $5.4 million from $4.5 million year-over-year.Gros

Jerash Holdings (US), Inc. (NASDAQ:JRSH) Q3 2025 Earnings Conference Call February 11, 2025 9:00 AM ETCompany ParticipantsRoger Pondel - IR,...

Jerash Holdings (US) Inc (JRSH) is set to release its Q3 2025 earnings on Feb 11, 2025. The consensus estimate for Q3 2025 revenue is $37.65 million, and the ea

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Jerash stock hits 52-week high at $3.58 amid robust growth

Jerash Holdings (US), Inc. (NASDAQ:JRSH) Q2 2025 Earnings Conference Call November 12, 2024 9:00 AM ETCompany ParticipantsRoger Pondel - Investor...

Jerash Holdings (US) Inc (JRSH) is set to release its Q2 2025 earnings on Nov 12, 2024. The consensus estimate for Q2 2025 revenue is $37.45 million, and the ea

Revenue: Increased 17.8% to $40.9 million from $34.7 million year-over-year.Gross Profit: $4.6 million, down from $5.6 million in the same quarter last year.Gr